title: Successful treatment of supraventricular tachycardia exhibiting hydrops fetalis with flecainide acetate. A case report.
abstract: BACKGROUND
  The efficacy of flecainide acetate for the treatment of fetal supraventricular tachycardia with hydrops fetalis and changes in venous blood flow patterns in the fetus during treatment are reported.
  
  
  METHODS
  Oral flecainide administration was started at 30 weeks of gestation. Cardioversion was achieved 6 days after treatment. Sustained abnormal venous Doppler indices were shown and complete normalization of venous returns was observed 6 days after cardioversion. A vigorous male baby was born, and he is now 1 year of age and in good condition with no medication.
  
  
  CONCLUSIONS
  Reversible cardiac dysfunction was observed even after cardioversion in the fetus with supraventricular tachycardia, which could be assessed precisely by venous Doppler analysis.
authors.affiliation: Perinatal Care Center, Yamaguchi University Hospital, Minamikogushi, Ube, Japan. miyabi@po.cc.yamaguchi-u.ac.jp
authors.forename: Masahiko
authors.initials: M
authors.lastname: Nakata
authors.forename: Kikue
authors.initials: K
authors.lastname: Anno
authors.forename: Lena Tashima
authors.initials: LT
authors.lastname: Matsumori
authors.forename: Motoki
authors.initials: M
authors.lastname: Fujiwara
authors.forename: Masahiro
authors.initials: M
authors.lastname: Sumie
authors.forename: Masakatsu
authors.initials: M
authors.lastname: Sase
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kato
mesh_terms: D000328:Adult; D005260:Female; D005424:Flecainide / Q000627:therapeutic use*; D006801:Humans; D015160:Hydrops Fetalis / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011247:Pregnancy; D013617:Tachycardia, Supraventricular / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014463:Ultrasonography
chemical_list: D005424:Flecainide